GSK360A是一种活性HIF-PHD抑制剂。GSK360A通过稳定HIF-1α信号传导而具有全身和局部作用,并可以改善长期的心室功能。 GSK360A is an active HIF-PHD inhibitor. GSK360A has systemic and local effects by stabilizing HIF-1α signaling and can improve long-term ventricular function.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
GSK360A
CAS number:931399-19-8 molecular formula:C17H17FN2O5
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | 2-[[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxoquinoline-3-carbonyl]amino]acetic acid | DTXSID10715754 | GSK360A | HY-123422 | N-[1-(2-Cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbonyl]glycine | AKOS040748476 | SCHEMBL8243641 | ||
| CAS number | 931399-19-8 | molecular formula | C17H17FN2O5 |
| molecular weight | 348.33 g/mol | Exact mass | - |
| PSA | 107.000 Ų | logp | 2.600 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





